{"id":"https://openalex.org/W2074628239","doi":"https://doi.org/10.1089/dia.2006.8.358","title":"In Vitro Stability of Insulin Lispro in Continuous Subcutaneous Insulin Infusion","display_name":"In Vitro Stability of Insulin Lispro in Continuous Subcutaneous Insulin Infusion","alternate_titles":[],"publication_year":2006,"publication_date":"2006-06-01","ids":{"openalex":"https://openalex.org/W2074628239","doi":"https://doi.org/10.1089/dia.2006.8.358","mag":"2074628239","pmid":"https://pubmed.ncbi.nlm.nih.gov/16800757"},"language":"en","primary_location":{"id":"doi:10.1089/dia.2006.8.358","doi":"https://doi.org/10.1089/dia.2006.8.358","is_oa":false,"landing_page_url":"https://doi.org/10.1089/dia.2006.8.358","pdf_url":null,"source":{"id":"https://openalex.org/S67495602","display_name":"Diabetes Technology & Therapeutics","issn_l":"1520-9156","issn":["1520-9156","1557-8593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technology &amp; Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2074628239"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061743166","display_name":"Michael R. DeFelippis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael R. DeFelippis","raw_affiliation_strings":["Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005581895","display_name":"Maureen A. Bell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maureen A. Bell","raw_affiliation_strings":["Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005522901","display_name":"Jennifer A. Heyob","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jennifer A. Heyob","raw_affiliation_strings":["Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052610955","display_name":"Sacha M. Storms","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sacha M. Storms","raw_affiliation_strings":["Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biopharmaceutical Research and Development, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I168537998"],"apc_list":null,"apc_paid":null,"fwci":2.3554,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.8865208,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"8","issue":"3","first_page":"358","last_page":"368"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9253000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.9253000020980835,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.012900000438094139,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14189","display_name":"Intravenous Infusion Technology and Safety","score":0.012600000016391277,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-lispro","display_name":"insulin lispro","score":0.9959999918937683},{"id":"https://openalex.org/keywords/continuous-subcutaneous-insulin-infusion","display_name":"insulin pump therapy","score":0.9890000224113464},{"id":"https://openalex.org/keywords/insulin-stability","display_name":"insulin stability","score":0.7459999918937683},{"id":"https://openalex.org/keywords/stress-testing","display_name":"stress testing","score":0.6710000038146973},{"id":"https://openalex.org/keywords/high-molecular-weight-proteins","display_name":"high molecular weight proteins","score":0.8640000224113464},{"id":"https://openalex.org/keywords/m-cresol","display_name":"m-cresol","score":0.8550000190734863},{"id":"https://openalex.org/keywords/insulin-adsorption","display_name":"insulin adsorption","score":0.5830000042915344},{"id":"https://openalex.org/keywords/insulin-potency","display_name":"insulin potency","score":0.32899999618530273},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.48899999260902405},{"id":"https://openalex.org/keywords/antimicrobial-preservation","display_name":"antimicrobial preservation","score":0.42899999022483826}],"concepts":[{"id":"https://openalex.org/C2776486108","wikidata":"https://www.wikidata.org/wiki/Q3492616","display_name":"Insulin lispro","level":4,"score":0.9163401126861572},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.7419214844703674},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7313708066940308},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.5812506079673767},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.5079997181892395},{"id":"https://openalex.org/C2776390293","wikidata":"https://www.wikidata.org/wiki/Q2035485","display_name":"Subcutaneous injection","level":2,"score":0.45584625005722046},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3941977918148041},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3102160692214966},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2942013144493103},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.22764721512794495},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.18494081497192383},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1751905083656311},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10452520847320557}],"mesh":[{"descriptor_ui":"D003408","descriptor_name":"Cresols","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003922","descriptor_name":"Diabetes Mellitus, Type 1","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005080","descriptor_name":"Exercise Test","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D007332","descriptor_name":"Insulin Infusion Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000098","qualifier_name":"blood supply","is_major_topic":false},{"descriptor_ui":"D061268","descriptor_name":"Insulin Lispro","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/dia.2006.8.358","doi":"https://doi.org/10.1089/dia.2006.8.358","is_oa":false,"landing_page_url":"https://doi.org/10.1089/dia.2006.8.358","pdf_url":null,"source":{"id":"https://openalex.org/S67495602","display_name":"Diabetes Technology & Therapeutics","issn_l":"1520-9156","issn":["1520-9156","1557-8593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technology &amp; Therapeutics","raw_type":"journal-article"},{"id":"pmid:16800757","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16800757","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes technology & therapeutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W15436629","https://openalex.org/W1524122182","https://openalex.org/W1874815452","https://openalex.org/W1978876908","https://openalex.org/W1988089792","https://openalex.org/W1991835641","https://openalex.org/W1998498176","https://openalex.org/W2012570045","https://openalex.org/W2023293560","https://openalex.org/W2034756707","https://openalex.org/W2047320146","https://openalex.org/W2065565878","https://openalex.org/W2082619509","https://openalex.org/W2091336973","https://openalex.org/W2123165496","https://openalex.org/W2143417213","https://openalex.org/W2145012784","https://openalex.org/W2150944287","https://openalex.org/W2163362541","https://openalex.org/W2172017678","https://openalex.org/W2298284891","https://openalex.org/W2312617496","https://openalex.org/W2769264260","https://openalex.org/W4234329496"],"related_works":["https://openalex.org/W2017645484","https://openalex.org/W2172017678","https://openalex.org/W2056175959","https://openalex.org/W2159061558","https://openalex.org/W2057488320","https://openalex.org/W1992092189","https://openalex.org/W2108068678","https://openalex.org/W2117503999","https://openalex.org/W2126888693","https://openalex.org/W3004902303"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,121,171,270],"stability":[2,347],"of":[3,135,173,192,197,207,214,256,272,280,321,335],"insulin":[4,11,136,208,215,239],"lispro":[5,34,137,143,184,209,216,240,343],"for":[6,79,86,186,250,266,348],"use":[7,349],"in":[8,37,221,235,298,350],"continuous":[9,87],"subcutaneous":[10],"infusion":[12,88,315],"(CSII)":[13],"therapy":[14],"was":[15,58,112,128,244,277],"evaluated":[16],"using":[17,154],"a":[18,61],"stress":[19,62,199,230],"test":[20,63],"incorporating":[21],"high":[22],"temperature":[23,68],"and":[24,51,72,94,138,149,163,237,304,319,328,354],"mechanical":[25,73,333],"agitation":[26,74],"combined":[27],"with":[28,301],"simulated":[29],"basal/bolus":[30],"administration.":[31],"METHODS:":[32],"Insulin":[33,142,183,342],"formulation":[35,164,176,307],"contained":[36],"MiniMed":[38,351],"507c":[39],"(Medtronic":[40],"MiniMed,":[41],"Sylmar,":[42],"CA),":[43],"H-TRONplus":[44],"(Disetronic":[45,54],"Medical":[46],"Systems,":[47],"St.":[48],"Paul,":[49],"MN),":[50],"D-TRON":[52,355],"CSII":[53,82,337,356],"Medtronic":[55],"Systems)":[56],"devices":[57,83,111,338],"subjected":[59],"to":[60,66,130,287],"involving":[64],"exposure":[65],"elevated":[67],"(37":[69],"degrees":[70],"C)":[71],"(shaking":[75],"at":[76,89,218],"100":[77],"strokes/min)":[78],"7":[80],"days.":[81],"were":[84,99,152,167,224,297,317,339],"programmed":[85],"0.8":[90],"U/h":[91],"(19.2":[92],"U/day),":[93],"three":[95],"6-U":[96],"bolus":[97],"doses":[98],"also":[100,168],"manually":[101],"delivered":[102,161,294],"each":[103,125,187,195,251],"day":[104,196],"(18":[105],"U/day).":[106],"Formulation":[107],"infused":[108,175],"from":[109,124,313],"the":[110,118,132,139,174,180,198,222,228,247,254,273,283,314,336],"collected":[113,312],"every":[114],"24":[115],"h":[116],"over":[117,246],"7-day":[119,229],"study.":[120,182],"material":[122],"obtained":[123],"24-h":[126],"period":[127,249],"analyzed":[129],"assess":[131],"physicochemical":[133,346],"properties":[134],"overall":[140],"formulation.":[141],"potency,":[144],"purity,":[145],"high-molecular-weight":[146],"protein":[147],"(HMWP),":[148],"m-cresol":[150],"content":[151],"determined":[153],"high-performance":[155],"liquid":[156],"chromatographic":[157],"methods.":[158],"Solution":[159],"pH,":[160],"volume,":[162],"physical":[165],"appearance":[166],"evaluated.":[169],"RESULTS:":[170],"pH":[172],"remained":[177,189,261,285,309],"unchanged":[178],"throughout":[179],"entire":[181],"potency":[185],"device":[188],"within":[190],"95-105%":[191],"label":[193],"claim":[194],"test,":[200],"indicating":[201],"that":[202,306],"adsorption":[203],"or":[204,332],"surface-induced":[205],"denaturation":[206],"did":[210,325],"not":[211,326],"occur.":[212],"Levels":[213],"deamidated":[217],"position":[219],"21":[220],"A-chain":[223],"essentially":[225],"constant":[226],"during":[227],"test.":[231],"A":[232],"time-dependent":[233],"increase":[234],"HMWP":[236],"other":[238,330],"chemical":[241],"transformation":[242],"products":[243,260],"observed":[245],"testing":[248],"device.":[252],"However,":[253],"levels":[255,284],"these":[257,267],"known":[258],"degradation":[259],"well":[262],"below":[263],"published":[264],"specifications":[265],"analytical":[268],"properties.":[269],"concentration":[271],"antimicrobial":[274],"agent,":[275],"m-cresol,":[276],"decreased":[278],"because":[279],"absorption,":[281],"but":[282],"sufficient":[286],"provide":[288],"protection":[289],"against":[290],"microbial":[291],"contamination.":[292],"Total":[293],"volume":[295],"results":[296],"good":[299],"agreement":[300],"expected":[302],"values":[303],"confirmed":[305],"viscosity":[308],"unchanged.":[310],"Samples":[311],"sets":[316],"clear":[318],"free":[320],"precipitates.":[322],"Occlusion":[323],"alarms":[324],"occur,":[327],"no":[329],"electronic":[331],"malfunctions":[334],"encountered.":[340],"CONCLUSIONS:":[341],"demonstrates":[344],"appropriate":[345],"507c,":[352],"H-TRONplus,":[353],"devices.":[357]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2074628239","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
